Skip to main content
. 2015 Sep 10;113(7):1027–1034. doi: 10.1038/bjc.2015.329

Figure 2.

Figure 2

Plasma levels of sVEGFR3 (A), PlGF (B), HGF (C) and ANGPT2 (D). Concentrations are displayed for mFOLFOX6-treated (White) and mFOLFOX6/Aflibercept-treated (grey) patients at baseline, 30 days after the first study treatment infusion, 60 days after first infusion and 30 days after last infusion. Plasma levels for PlGF are log-transformed to allow visualisation of low levels of PlGF.